People with schizophrenia and schizoaffective disorder are no strangers to medication changes (Mental Health Medication Changes Require a Doctor's Input). Maybe the medicinal cocktail prescribed isn't relieving symptoms …
Insel notes the obvious: wealthy tech companies have realized that health care is a bigger business than software and gadgets (it's about 20 percent of the U.S. GDP), and so it's one they should get into. But he says he also …
18, 2015 (HealthDay News) — A new antipsychotic drug to treat schizophrenia and bipolar disorder in adults has been approved by the U.S. Food and Drug Administration. The drug, Vraylar (cariprazine), is a capsule taken …
Research has linked the abnormal behavior of two genes (BDNF and DTNBP1) to the underlying cause of schizophrenia. Schizophrenia is a devastating mental disorder that affects nearly 1 percent of the total human …
On Thursday, the U.S. Food and Drug Administration (FDA) approved Vraylar (cariprazine) capsules to treat schizophrenia and bipolar disorder in adults
